The cost of allogeneic red blood cells--a systematic review.
Several reports suggest that the cost of RBCs may have risen over time, but there exists very little published evidence of that. The objective was to determine whether published studies documenting cost data on RBCs suggest an increase over time and to assess the quality of cost studies. We used the terms 'cost', 'allogeneic/allogenic' and 'blood' to identify cost studies between 1966 and 2002 from Medline, ISIesource and Ingenta electronic databases. Furthermore, we manually searched a number of transfusion and health economics journals for completeness. We included studies that used an established methodology and conducted an economic evaluation using primary/secondary cost data to calculate the cost of RBCs and RBC transfusion. Studies without allogeneic RBCs as comparator were excluded. Two individuals independently reviewed the studies and included studies upon reaching a consensus. Fourteen studies qualified the selection criteria and were included in the review. Ten studies were identified from Medline, two from Ingenta, one from ISIesource and one was a conference paper. Of the 14 studies reviewed, 10 had focused on RBC transfusion and four had focused on both RBCs and RBC transfusion. Ten studies were from the US, and two each from Canada and the UK, respectively. Two studies had explicit objective of cost calculation, and others had calculated costs towards fulfilling other objectives. Most of the reviewed studies were dated and of poor quality. Despite these limitations, it appears that the cost of RBCs has increased over time in the UK, Canada and the US. More studies are needed to fully assess the trend of costs over time. Future cost studies should try to follow the economic evaluation guidelines for greater research implications.
Amin
M
M
Clinical Epidemiology Program, Ottawa Health Research Institute and the University of Ottawa Centre for Transfusion Research, Ontario, Canada. mamin@ohri.ca
Fergusson
D
D
Aziz
A
A
Wilson
K
K
Coyle
D
D
Hébert
P
P
D002170:Canada; D003365:Costs and Cost Analysis / Q000706:statistics & numerical data / Q000639:trends; D003625:Data Collection / Q000379:methods*; D019992:Databases as Topic; D017707:Erythrocyte Transfusion / Q000191:economics*; D011642:Publications; D006113:United Kingdom; D014481:United States